Skip to main content
Caplight Logo









Kaspard

Kaspard

Private
BrusselsHealthcare & Life Scienceshttps://kaspard.com/

Last Round

Series A

Jul 15, 2021

Total Funding Raised

$3.66M

Company Overview

Kaspard operates in Healthcare & Life Sciences and is based in Brussels. Its latest recorded funding round was a Series A round in July 2021.

Kaspard is a health technology company that provides sensor-based monitoring and fall detection solutions for nursing homes and hospitals.

Sector

Healthcare & Life Sciences

Verticals

Health IoT, Medical Devices, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Kaspard Comparables

Compare Kaspard with similar companies based on industry and business-model similarity.

Kaspard comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MintT
94%
Cogvis
89%
NOBI
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Kaspard Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 15, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Sebastiaan Vermeersch

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Kaspard Investors

Notable investors and investment history

Kaspard investors
InvestorRounds
ScaleFundSeed, Series A
finance&invest.brusselsSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 1931% MoM, from 32 to 650.

  • Mar 1, 2026

    Monthly visitors increased 82% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Kaspard Filings

Explore SEC and related filing metadata, where available.

Kaspard filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Kaspard's valuation, stock price, and market status.

Is Kaspard a public or private company?

Kaspard is a private company.

What is the current stock price of Kaspard?

Kaspard is a private company, so its shares have no public market price. Caplight tracks Kaspard's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Kaspard worth (valuation)?

Valuation information for Kaspard is not publicly available.

Can I buy Kaspard stock?

Kaspard shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Kaspard's last funding round?

Kaspard's most recent funding round was Series A on July 15, 2021.

Who are the main investors in Kaspard?

Key investors in Kaspard include ScaleFund, finance&invest.brussels.

Will Kaspard IPO soon?

No public IPO plans have been announced for Kaspard.

How can I track Kaspard secondary market activity?

Caplight tracks bids, offers, and trades in Kaspard's shares on secondary markets.

Firmographic Details

HeadquartersBrussels
Employee Range9
Year Founded2017
Last FundingJul 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?